{"name":"Seelos Therapeutics, Inc.","slug":"seelos-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxQRHJtakxvdkRYZ3J2azgyVWJiMVJpdDNZSFBQbEFfakVCcjZ0dUsydlVOMTlxa2pFdUdVengtendsdmJ2UG9nYzB5aVBJc1pYMmJwbnVkeTdlZ0xEMDRVVVBrYnFrN1lsNmo4VGlKdkdCSnV0c3VkdzlmRFluXzgtbmVNQURBNFpKa00tZDlWeXBod3hLR3ExTmpLbUxRTGFkMThDV0FmMk54VHJpeEhWbzRoSEhXVUlsYi1Ca2QyV3dPbWxvV0ZqMGFqbnN4Rk5Wd3N6ZUZ0dVR1MGpMdzF6eFhLN1l2a1MxbnFock1VU0ZMY0RHRTBHUmVB?oc=5","date":"2026-04-02","type":"trial","source":"Barchart.com","summary":"Motor Neuron Disease Clinical Trial Pipeline Shows Potential with Active Contributions from 180+ Key Companies | DelveInsight - Barchart.com","headline":"Motor Neuron Disease Clinical Trial Pipeline Shows Potential with Active Contributions from 180+ Key Companies | DelveIn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBrU0pwZWwzR2QxcXRpUEU0UEhIZzVsUUNWS2pSSWxxY25VQVd6enNmdDVzM091d1l0cmZTZ2dIMmNxWGUyV3d4Tk1feVQ0TndYY3UzYXpxa0lSN0Q2b0dVZ09mcHZHY1dKNnk4LThod3VYWENwVDU4?oc=5","date":"2025-10-31","type":"pipeline","source":"Fierce Biotech","summary":"The 2025 Biotech Graveyard - Fierce Biotech","headline":"The 2025 Biotech Graveyard","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxOVjFtTm1MYS1UMDFtaHZJd0lTU1NkU0p4NzBRNktMRnRrazF4UlFLeVJEQUdHVFQtQkQ4b3lfaE5ZUWZIcDFMTTVKaGh5UXp0dVhNUnc5RWItVVFJdzZlcHpFMFNtTUREbWtkSXpIMzA1ZTVQUVZuQThad3lsOFZiYmJmYTItbm9CSmdOcUJNZW5wT09GYVljZXFHZm1GTEFnMVg1RWZjRVZCbE1zWUpDT3gyenVZWWtPTlB4UU5JSmFGaTZEcDBVNkxVOW54Njk4OGRWTlVBQWI4eEl1QkRGZjg0QnJBa2tsem5EcWUxR2JoMVExc3NBcTR5TmsxWDVWSTBOOXcyOGlCX3M?oc=5","date":"2025-10-21","type":"deal","source":"globenewswire.com","summary":"GLD Partners, LP Acquires Seelos Therapeutics, Inc. Assets, Strengthening GLD’s Growing Life Sciences Portfolio - globenewswire.com","headline":"GLD Partners, LP Acquires Seelos Therapeutics, Inc. Assets, Strengthening GLD’s Growing Life Sciences Portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNeGlhUDUwajRfTGVnVkFqbUdxUE51eFFwc2NXYkdrdS0teUhyeVBCWFBER3NhaGZTVkt4ajh2c0xkbl95Q1dKV3F4X0oyR1FDaFNxYjY4NE9VNTFGLWZTdWNscklkcmVUa0tGRW9nN21Jb1E2X3RRcVNsdWRWSFBXdER2SmM?oc=5","date":"2025-09-30","type":"pipeline","source":"Research Nester","summary":"Psilocybin Assisted Therapy Market Size, Growth Forecast 2035 - Research Nester","headline":"Psilocybin Assisted Therapy Market Size, Growth Forecast 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNbUhxZGZQQkFLV0w5b0gwNHh0bXRuVV9Kbll0YWNXQWtnTHFvUWs3WHF0QjR0VktiMWRicXc4d2VCbDFMdm53TXl5cDhyMFkxcU5hd0NNcHE1bGY3Mndxcld4Q2ZFdG1zdGx0WFRBdmQxbnE2emxMNEF0RWNfc3RwQVlqeXFWZnh4c1VQazJuVGJMWU9SN0JHVWl1a3hYTFd6SlpzM2tSNEFhUkk?oc=5","date":"2024-11-22","type":"pipeline","source":"Investing.com","summary":"Seelos Therapeutics files for Chapter 11 bankruptcy - Investing.com","headline":"Seelos Therapeutics files for Chapter 11 bankruptcy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQVjk3TFJkdEFCYWhQcVRudGdkaFZfdXVveVlvdkFsazBKbU4weWZUdHRTOFN5M25yV25wRGllekVLT2x4cVowZWk2TUlGT0lEMG9YWjJtU2t2TEFpZ2hDbUVmUmZjcHd5Y2VNUER6bTNXVFdSbkFERWt6Z2VwcHpsZTEzNGVvWDVidm85bXc2V3QwNlF4bUo0aQ?oc=5","date":"2024-11-22","type":"trial","source":"Fierce Biotech","summary":"After ALS trial misses mark, Seelos has filed for bankruptcy - Fierce Biotech","headline":"After ALS trial misses mark, Seelos has filed for bankruptcy","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNeW5BekMyN0VBdjFXVHlFR0pKTnMwcHgteTQtcWR4VkF1MUJQdUtEM1RaS3pJdWZQaDJwZ2FwLThuNFo0YnZwaWRfN2xJcTc1cXdsWmRMZXotWkJNeHJpaWRpVlhSVVp0dDVfSGRQOVd2VjU4T3hPcllvVXNUVlctTUhPdmpJZDN5Zk5tcDU1cmtFcy1rcTdnSWtqeUZZcTl6UklUdFNwU0R1eDdlZWlqX2lUcjd5UFgwcDJqUkx4d0dLNUlUa3YtR0IxMUhHSWVGTV9TdEc3ZVg3aXdOX1hnalZQUlNZamJpcG9SaWotNFRrcFZuM3ZYU2pscTU?oc=5","date":"2024-10-15","type":"pipeline","source":"PR Newswire","summary":"Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market - PR Newswire","headline":"Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFAzYUJNWjQwd1hIVnA2NHJoblQxWWxCNTBWR095czdTR1FQdXQ3dmg0M2s3eE5RUWxzQnRRQTNrWFBWa0I4clJRbmxHM2dvQU9NV2NvS3BXWTRjN0hSM0pZ?oc=5","date":"2024-10-15","type":"pipeline","source":"ChartMill","summary":"SEEL Stock Price, Quote & Chart | SEELOS THERAPEUTICS INC (NASDAQ:SEEL) - ChartMill","headline":"SEEL Stock Price, Quote & Chart | SEELOS THERAPEUTICS INC (NASDAQ:SEEL)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxPb3ZHZGFBS3V0M0l6djhKa2tFdHdSemtBcVZ6bUJaWlpOQ1VuajBsUU1WMFhkbVlNTG9mbG5pb2plMUlMdWV6SWN3UEtfcVFDM3h1cy1McDk3OE9WWmZGQVlLVnFzREwxWlJnT3hNSmkyNTd4R0ZicGFiYUc5Q2d3YW50MG1wMlA1ZjVLVHlQeHZ1dmJXWlIzV29ZT0t5MzQwclZLZkZhXzMtODJtMmxHVlBfaDdxRUtnQWV3cU1JLWJuOXdBUEJqVlh1c3dZNHRnVWVOaW5KaThkb2Nwa2VIcUx6ZFdtOXh1SjU5S1JIcnpUSVdUb0JXeDNERk80eTlDU2RmOHJrWXdxUS1RRXFEYklGZ1pwbERsdmNQdmItM0lYdWVmOTM0UmZfckxDTlFnbkJRVk50M1JLMThTREs3N2xYSFZocy1hRWp3UENEeHA?oc=5","date":"2024-09-24","type":"pipeline","source":"PR Newswire","summary":"Seelos Therapeutics announces the signing of a Material Transfer Agreement with U.S. Army Medical Materiel Development Activity (USAMMDA) to evaluate SLS-002 for treatment of PTSD - PR Newswire","headline":"Seelos Therapeutics announces the signing of a Material Transfer Agreement with U.S. Army Medical Materiel Development A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxOS01GTlE3ZEt2dlJ6X0xPWTh4MGQxRFBJN1RaMkRFU0c4SjA0M2x1S1c5ZkszZHU3ZUtCSERUazZOak00eklZbjJJTjZpMVR2c3g3V1IxMGRIdjJxVEZBOEFGQzE4WUx4aHdGMDlVX21iNkJJVVcwOFdhS3JvT3l4Q1VQc1QwUWhpSkhZQ2JlMG5JczMycm0zOWJOZHBiY0xiUU9sSTQ1VXBVNHU2dDFKV1lxSFFvWkt1ZlFZY09qNjl1U0txanpUcUd4RnRWRDlqaE9paHBFWUc1UnJXU3YyVVVjaFZJcmtiMGR3dVE4c0hYN29w?oc=5","date":"2023-09-27","type":"trial","source":"BioSpace","summary":"Seelos Therapeutics Announces Encouraging Data from an In Vivo Study of SLS-005 in an Aggressive Preclinical Model of Alzheimer's Disease - BioSpace","headline":"Seelos Therapeutics Announces Encouraging Data from an In Vivo Study of SLS-005 in an Aggressive Preclinical Model of Al","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOeFV4VGU3cmg4dXJkRWFuaUEtN2hTbDlHYlBHWjF0V1kwWlZSeTBWQlRxMDN3MGprS2hOR3E4WWIwclBrenB5ZkwtX20zajlla0d2d1o4Ql9aZG9uOVdtVFhZMFpBTnZRQ2lVdU5RcHZXbkFZQUR6QjNXUjRYM2pPTkxodWI5UHY1Vzl1ZFBGRFMxZzZoTmFFNExocFV6MWVhRmJZTEJxcDM4X2llMlNaRWZQaWt3VjNSbGN4aXhuMFEtUDI5bk1lRV9aeExXNGwwTmRRbGthYUdLNElsRkhmNmNEOTJlOHpUOFZiN0RZYjBRZ1M1UTlGT1BTcjc?oc=5","date":"2023-09-20","type":"trial","source":"BioSpace","summary":"Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide - BioSpace","headline":"Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at I","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPOTFnckYtQjAzX3N1enlTVkh2ZW1hWGR1SHd5NUlHWk9ZMDRmMGFpeWRLZWQ3UkZGZHVLaEowclhPOUdIaGdPU01aX0Zpb0dEaHVIeTV5V0o5VjdoOVVNZ0tZU2ZnUm9CV2RSdU0yOG56YzFjYm51Ni1HckQyc0RuUEl5MzB2cE51UFRoSHk4Z2RYOFhiYnMwTjdRNWdxakU1a2R0a1hfdTBPN1FMOFNJNmxaLXE3Y3huS3c?oc=5","date":"2019-01-17","type":"pipeline","source":"MarketWatch","summary":"Ligand Pharmaceuticals stock down after extremely critical Citron report - MarketWatch","headline":"Ligand Pharmaceuticals stock down after extremely critical Citron report","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}